|
|
|
|
Vol. 59, Issue 4, 929-938, April 2001
2a-Adrenergic Receptor Conformational
Stability and Cell-Surface Turnover
Department of Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee
| |
Abstract |
|---|
|
|
|---|
Functional and structural data from G protein-coupled receptors
(GPCR) predict that transmembrane-domain (TM)2 is adjacent to TM7
within the GPCR structure, and that within this interface a conserved
aspartate in TM2 and a conserved asparagine in TM7 exist in close
proximity. Mutation at this D79(TM2)-N422(TM7) interface in the
2A-adrenergic receptor (
2AAR) affects not
only receptor activation but also cell-surface residence time and
conformational stability. Mutation at TM2(D79N) reduces allosteric
modulation by Na+ and receptor activation more dramatically
than affecting cell-surface receptor turnover and conformational
stability, whereas mutation at TM7(N422D) creates profound
conformational instability and more rapid degradation of receptor from
the surface of cells despite receptor activation and allosteric
modulation properties that mirror a wild-type receptor. Double mutation
of TM2 and 7(D79N/N422D) reveals phenotypes for receptor activation and
conformational stability intermediate between the wild-type and singly
mutated
2AAR. Additionally, the structural placement of
a negative charge at this TM2/TM7 interface is necessary but not
sufficient for receptor structural stability, because mislocalization
of the negative charge in either the D79E
2AAR (which
extends the charge out one methylene group) or the
D79N/N422D
2AAR (placing the charge in TM7 instead of
TM2) results in conformational lability in detergent solution and more
rapid cell-surface receptor clearance. These studies suggest that this
interface is important in regulating receptor cell-surface residence
time and conformational stability in addition to its previously
recognized role in receptor activation.
| |
Introduction |
|---|
|
|
|---|
The
2-adrenergic receptors
(
2AR) are members of the superfamily of seven
transmembrane spanning G protein-coupled receptors (GPCR) and are
coupled via Gi/Go proteins to multiple effectors in native cells such
as inhibition of adenylyl cyclase (Limbird, 1988
), suppression of
voltage-gated Ca2+ currents (Horn and McAffee,
1980
), activation of receptor operated K+
currents (Morita and North, 1981
), and stimulation of the
mitogen-activated protein (MAP) kinase cascade (Richman and Regan,
1998
).
Cell-surface receptor expression is necessary for extracellular to
intracellular communication mediated by circulating hormones. Mechanisms regulating the long-term cell-surface residence time of
GPCRs are poorly understood. For the
2AAR, the
presence of the third intracellular loop (Edwards and Limbird, 1999
) as
well as conformational stability (Wilson and Limbird, 2000
) contributes to maintaining long-term (approximately 12-14 hours) cell-surface receptor residence time, albeit through differing mechanisms. Although
conformational stability likely contributes to maintaining or
permitting cell-surface receptor expression, sites critical for
maintaining conformational stability within GPCR structure are only
beginning to be elucidated. One such site apparently critical for
regulating
2AAR conformational stability is
the highly conserved D79 residue, located in a topologically homologous position in all amine-binding GPCR in TM2 (Wilson and Limbird, 2000
).
The three-dimensional structural characterization of bacteriorhodopsin
and subsequently bovine rhodopsin (Unger et al., 1997
; Palczewski et
al., 2000
), in conjunction with intentional mutagenesis strategies
coupled with functional studies (Mizobe et al., 1996
; Gether and
Kobilka, 1998
), has led to a proposed arrangement of the seven helices
of GPCR within the bilayer. For amine-binding GPCR, a hydrogen bonding
network consisting of at least a conserved aspartate in
transmembrane-domain 2 (TM2) and an asparagine in TM7 is postulated to
serve as a critical link between agonist occupancy and G protein
activation. An exception of nature is the gonadotropin releasing
hormone (GnRH) receptor, where these two residues are interchanged such
that there exists an asparagine in TM2 and an aspartate in TM7 (Zhou et
al., 1994
). Exchanging these residues between TM2 and TM7 in the GnRH
receptor (creating the N87D/D318N GnRH-R) results in a receptor
structure that retains high affinity agonist binding and coupling to G
proteins, albeit not to the same extent as the wild-type receptor. A
single mutation, N87D in TM2 of the GnRH receptor, however, leads to
loss of G protein coupling, presumably because of disruption of this
hydrogen bonding network, which serves to regulate receptor activation (Zhou et al., 1994
). For the GnRH receptor, this interface can also
affect receptor expression in transfected cells (Flanagan et al.,
1999
). An analogous interaction between an aspartate in TM2 and an
asparagine in TM7 has been demonstrated for the
5HT2A-receptor (Zhou et al., 1994
) and for the
µ-opioid receptor (Xu et al., 1999
). In contrast, complementary
TM2/TM7 interface mutation in the cannabinoid CB1 receptor does not
restore receptor-mediated potentiation of inwardly rectifying potassium
channel current or receptor internalization (Roche et al., 1999
),
indicating greater complexity of this predicted charge relay system or
lack of generality among all GPCR subclasses. Additionally, the recent
crystal structure of rhodopsin reveals that Asp83 (TM2) and Asn302
(TM7) are probably too far apart for a direct hydrogen bonding
interaction although they may be bridged by a water molecule, revealing
a proximity between TM2 and TM7 in GPCR structure (Palczewski et al.,
2000
).
With regards to the
2AAR, previous studies
have implicated several consequences of mutating this highly conserved
aspartate (D79) in TM2 including: 1) changes in allosteric modulation
of receptor conformation by monovalent cations, such as
Na+ (Horstman et al., 1990
; Neve et al., 1991
;
Kong et al., 1993
; Tian and Deth, 1993
), 2) altered cell surface
residence time of the
2AAR, and 3) diminished
conformational/structural stability of the receptor, manifest by loss
of functional binding capacity in detergent preparations without
parallel changes in receptor protein (Wilson and Limbird, 2000
). The
present studies explored the role of the conserved TM2(D79)/TM7(N422)
interface in the
2AAR and evaluated what role
this interface plays in regulating conformational stability,
cell-surface residence time and multiple functional properties of the
2AAR.
| |
Materials and Methods |
|---|
|
|
|---|
Molecular Modeling.
To generate a schematic of the proposed
proximity of D79 in TM2 and N422 in TM7 of the
2AAR, molecular modeling was used to generate
a simplified model of this receptor. De novo modeling of the
2AAR was performed via e-mail using SWISS
MODEL in the GPCR mode
(http://www.expasy.ch/swissmod/SWISS-MODEL.html). Briefly, the predicted transmembrane domain spans for the
2AAR were entered into the program using the
human
2-AR as the template for modeling. SWISS
MODEL then generated models with ProModII and conducted energy
minimization with Gromos 96 (Peitsch et al., 1996
; Ghex et al., 1999
).
Swiss-PdbViewer was then used to analyze and visualize the results
(Fig. 1).
|
DNA Reagents.
Porcine hemagglutinin (HA)-tagged wild-type,
D79N, D79E, and D79Q
2AAR have been described
previously (Ceresa and Limbird, 1994
). The N422D mutation was
engineered simultaneously into the wild-type and D79N backbones in the
pCMV4 mammalian expression vector using QuickChange Site-Directed
Mutagenesis (Stratagene, La Jolla, CA). Two complementary
oligonucleotides generating the N422D mutation with an additional
BamHI site to facilitate screening (antisense,
5'-GTAGATAACCGGATCCAGCGAGCTGTTGCAGTAG-3'; sense,
5'-CTACTGCAACAGCTCGCTGGATCCGGTTATCTAC-3') were used in polymerase chain
reactions according to the manufacturers instructions, except that 10%
dimethyl sulfoxide was used in the reaction to facilitate extension of
the template. Colonies were screened via BamHI digest of
minipreps and the entire coding region of the N422D and D79N/N422D
mutants was then sequenced with
33P-thermosequenase-cycle sequencing.
Cell Culture and Transfection. EcR-CHO (Chinese hamster ovary cells engineered for the ecdysone-inducible expression system obtained from Invitrogen, (Carlsbad, CA) cells were maintained in Ham's F-12 medium supplemented with 10% fetal calf serum (FCS), 2 mM glutamine, and 100 U/ml penicillin G sodium with 100 µg/ml streptomycin sulfate (pen-strep). Human embryonic kidney (HEK) 293 cells were maintained in minimal essential medium supplemented with 10% FCS plus pen-strep. EcR-CHO and HEK293 cells were plated the day before transfection at a density of 2 × 106 cells per well of a six-well plate or 35-mm dish. Cells were transiently transfected with the use of FuGENE-6 (Boehringer Mannheim) according to the manufacturer's instructions. Cells were assayed approximately 48 h after transfection.
Guanine Nucleotide Sensitivity of Radiolabeled Agonist Binding as
a Measure of
2AAR-G protein Coupling.
To evaluate
the ability of Gpp(NH)p, a hydrolysis-resistant GTP analog, to modulate
radiolabeled agonist binding, membranes from HEK 293 cells transiently
expressing receptor were lysed in hypotonic lysis buffer [15 mM HEPES,
5 mM, EDTA, 5 mM EGTA, pH 8.0 (with the addition of 10 U/ml aprotinin
and 0.1 mM PMSF)]. Cells were scraped on ice into ice-cold hypotonic
lysis buffer and passaged five times through a 25-gauge needle on ice
and centrifuged for 15 min at 40,000g, followed by
resuspension in lysis buffer and recentrifugation. Membranes were then
resuspended in 50 mM Tris-HCl, 10 mM MgCl2, and 5 mM EGTA, pH 8.0. Incubations (100 µl) containing membranes, 0.9 nM
para-[125I]iodoclonidine
([125I]PIC) agonist radioligand (approximately
160,000 cpm/100-µl incubation) and none (control) or increasing
concentrations of Gpp(NH)p were incubated for 30 min at 25°C.
Reactions were terminated via vacuum filtration using a Brandel Cell
Harvester and ice-cold 25 mM glycylglycine, pH 7.6. Filters were then
counted in a Beckman 4000 gamma counter (Beckman Instruments, Palo
Alto, CA).
Assessment of Allosteric Modulation of
2AAR
Conformation by Na+.
Epinephrine was evaluated as a
competitor for [3H]RX821002, a radiolabeled
antagonist, in the presence or absence of Na+
(Horstman et al., 1990
; Ceresa and Limbird, 1994
; Lakhlani et al.,
1997
). Transiently transfected HEK 293 cells expressing receptor were
lysed, centrifuged, resuspended, and recentrifuged as outlined above.
Membranes were then resuspended in a small volume of lysis buffer using
a 25-gauge needle. A small volume of membranes was then added to a
binding reaction consisting of 25 mM HEPES, 40 mM glycylglycine, 100 mM
NaCl or N-methyl D-glucamine chloride, and 5 mM EDTA, pH 8.0 (final volume, 250 µl) and
[3H]RX821002 with none (control) or various
concentrations of epinephrine (competitor). Reactions proceeded at
25°C for 30 min and were terminated as above. Filters were counted in
Aquasol (Packard, Meriden, CT) in a Packard 1600 TR scintillation counter.
Mitogen-Activated Protein Kinase Assay.
The ability of
receptor to activate MAP kinase was evaluated in HEK 293 cells
transiently expressing
2AAR, WT, or mutant structures. Cells were serum starved overnight starting 24 after transfection. The following day, response to various concentrations of
epinephrine (in serum-free medium) was examined for 2 min using one
transfected 35-mm dish per condition. The agonist-containing medium was
then aspirated and the incubation was terminated by scraping cells into
100 µl SDS-sample buffer consisting of 62.5 mM Tris-HCl, pH 6.8, 2%
(w/v) SDS, 10% glycerol, 50 mM dithiothreitol, 0.1% bromphenol blue
(with the addition of 2 mM Na-orthovanadate). This lysate was passaged
twice through a 25-gauge needle and then placed on ice. Samples were
then sonicated for 30 s and heated at 95°C for 5 min followed by
centrifugation at 13,000g for 5 min. An aliquot (40 µl)
was then subjected to 10% SDS-PAGE followed by Western analysis for
using both anti-active and anti-total MAP kinase antibodies as
described previously (Schramm and Limbird, 1999
).
Assessment of Ligand-Dependent Receptor Density
Up-Regulation.
To assess the effect of agonist or antagonist
occupancy on steady-state
2AAR density,
EcR-CHO cells transiently expressing WT or mutant
2AAR were incubated in serum-free medium
containing 0.1 mM ascorbate alone or ascorbate with 100 µM
epinephrine or 10 µM idazoxan for 16 to 24 h. Cells were then
washed three times with phosphate-buffered saline, pH 7.4, prewarmed to
37°C to facilitate removal of ligand. Triplicate wells of a six-well
plate were then scraped and pooled in 1.2 ml of ice-cold buffer
consisting of 25 mM glycylglycine, 40 mM HEPES, 5 mM EDTA, 5 mM EGTA,
pH 8.0, 10 U/ml aprotinin, and 0.1 mM PMSF and homogenized with five
up/down strokes of a 25-gauge needle on ice. Total cell lysate was then subjected to binding analysis using a saturating concentration of
[3H]RX821002 (10 nM). Nonspecific binding was
defined as that binding detected in the presence of 10 µM
phentolamine. Samples were normalized for milligrams of protein using a
protein assay kit (Bio-Rad, Hercules, CA) as outlined above.
Assessment of Cell Surface Receptor Turnover.
To assess cell
surface receptor turnover, receptors were first "up-regulated" by
overnight treatment with idazoxan to increase the sensitivity of the
assay for the mutant receptors (Fig. 3C). After overnight treatment,
cells were washed three times with 37°C PBS to wash out the idazoxan,
twice on ice with 4°C PBS, and biotinylated at 4°C with 1 mg/ml
sulfosuccinimidobiotin (sulfo-NHS-biotin; Pierce Chemical, Rockford,
IL) in PBS. Cells were then transferred to 37°C serum free medium
with or without receptor ligand (10 µM idazoxan or 100 µM
epinephrine in the presence of 100 µM ascorbate) and placed in a
37°C, 5% CO2 incubator. At the time points
indicated in Fig. 3A, medium was aspirated from the cells and
duplicate wells of a six-well plate were placed on ice and scraped into 500 µl/well of 4 mg/ml dodecyl-
-D-maltoside, 0.8 mg/ml
cholesteryl hemisuccinate, 20% glycerol, 25 mM glycylglycine, 20 mM
HEPES, 100 mM NaCl, 5 mM EGTA, pH 8.0, 0.1 mM PMSF, and 10 U/ml
aprotinin (called D
M/CHS extraction buffer), pooled and passaged
five times on ice through a 25-gauge needle. Cellular debris was
cleared from solubilized protein via centrifugation at 13,000 rpm in a Microfuge at 4°C for 30 min. This supernatant, referred to as the
detergent-solubilized preparation, was then incubated with 50 µl of
streptavidin-agarose overnight at 4°C on an inversion wheel. The
streptavidin-agarose was washed twice with 0.5 mg/ml dodecyl-
-D-maltoside, 0.1 mg/ml cholesteryl
hemisuccinate in 25 mM glyclyglycine, 20 mM HEPES, 100 mM NaCl, 5 mM
EDTA, pH 8.0 (called D
M/CHS wash buffer), and then eluted into 150 µl of SDS sample buffer with 15 min at 90°C. These samples were
then subjected to SDS-PAGE and transferred to nitrocellulose in a
buffer containing 10 mM CAPS, pH 11.0, and 10% methanol for 1.2 h
at 1 A. Nitrocellulose was blocked in Tris-buffered saline with
1% Tween 20 containing 5% nonfat dry milk for 1 h at room
temperature. HA-tagged receptor was then detected by blotting with a
1:1000 dilution of HA.11 primary antibody (Covance Research Products,
Berkeley, CA) in blocking buffer followed by anti-mouse
horseradish peroxidase-conjugated secondary antibody and enhanced
chemiluminescence detection (Amersham Pharmacia Biotech, Piscataway,
NJ). For semiquantification of Western analyses, films were digitized
by scanning into Adobe Photoshop (Adobe Systems, Mountain View CA) and
analyzed with NIH image software.
Assessment of Stability of Receptor Binding and Receptor Protein
in Detergent-Solubilized Preparations.
Transiently transfected COS
M6 cells expressing wild-type or mutant
2AAR
were rinsed with PBS 48 h after transfection. Cells were then
biotinylated at room temperature with 1 mg/ml sulfosuccinimidobiotin in
PBS, as above. The biotinylation solution was then aspirated and cells
were scraped on ice into ice-cold 15 mM HEPES, 5 mM EDTA, and 5 mM
EGTA, pH 7.6 (with the addition of 10 U/ml aprotinin, 0.1 mM PMSF, 1 mg/ml soybean trypsin inhibitor, and 1 mg/ml leupeptin) and passaged
five times up/down through a 25-gauge needle on ice. Lysates were then
centrifuged at 40,000g for 15 min at 4°C. Pellets were
resuspended on ice into D
M/CHS extraction buffer (with the addition
of 10 U/ml aprotinin, 0.1 mM PMSF, 1 mg/ml soybean trypsin inhibitor
and 1 mg/ml leupeptin). Receptor was solubilized by 10 up/down strokes
in a Teflon/glass homogenizer on ice. Cellular debris was cleared from
solubilized protein by centrifugation at 13,000 rpm in a Microfuge for
30 min at 4°C. The supernatant fraction was defined as the
detergent-solubilized receptor. To assess receptor stability over time,
enough detergent solubilized protein was added to the binding reactions
to achieve 0.25-0.5 pmol of bound receptor at time 0 (immediately
after solubilization and clearance from cellular debris). Change in
functional binding capacity was followed as a function of time by
keeping the detergent-solubilized receptors at 25°C and assaying the
same volume of solubilized preparation per binding reaction at
different time points (Wilson and Limbird, 2000
). Specifically, the
detergent-solubilized preparation was then warmed to 25°C. At the
given time points, after incubation at 25°C, aliquots were removed
and incubated with 40 µl streptavidin-agarose and 7.5 nM
[3H]yohimbine in D
M/CHS wash buffer (total
reaction volume, 500 µl) at 4°C on an inversion wheel for 1 to
1.5 h. Beads were then washed twice with D
M/CHS wash buffer.
The remaining beads were then directly added to scintillation cocktail
(Aquasol) and counted on a Packard scintillation counter. The stability
of receptor protein in these same samples was confirmed by Western
analysis of the HA epitope in the
2AAR
proteins using the HA.11 antibody, as described above.
| |
Results |
|---|
|
|
|---|
To assess retrograde communication (G
R) between G proteins and
WT and mutant
2A-AR structures, we examined
the ability of Gpp(NH)p to decrease receptor affinity for agonists,
measured by the loss of trapability of the
[125I]PIC radiolabeled agonist as a function of
increasing concentrations of the hydrolysis-resistant GTP analog,
Gpp(NH)p (Ceresa and Limbird, 1994
). As Gpp(NH)p concentrations are
increased, the fraction of receptors in the higher affinity R-G complex
(Kapp
0.4 nM) is diminished, as is the
fraction of receptors that can be detected using the
[125I]PIC agonist radioligand (Baron and
Siegel, 1990
). The lower affinity interactions [R + G-Gpp(NH)p] with
the receptor are not trapable using [125I]PIC
as the radioligand (Baron and Siegel, 1990
; Ceresa and Limbird, 1994
;
Keefer et al., 1994
) (Fig. 1C, schematic). As shown in Fig. 1C, more
than 80% of the WT [125I]PIC-specific binding
detected is eliminated when incubations contain 100 µM Gpp(NH)p,
consistent with the interpretation that the
[125I]PIC binding assay predominantly detects
radioligand binding to high-affinity R-G complexes. Similar findings
and interpretations have been obtained for radiolabeled agonist-binding
to
2-AR using [3H]UK
14304 (Gerhardt et al., 1990
) or to
2-AR using
other radiolabeled agonists (Stadel et al., 1980
).
[125I]PIC binding to the
D79N
2AAR is relatively insensitive to the
addition of Gpp(NH)p (Fig. 1C) (Ceresa and Limbird, 1994
). In contrast,
both the N422D and the D79N/N422D
2AAR possess
[125I]PIC binding that is readily diminished in
detectability in the presence of Gpp(NH)p (Fig. 1C). Compared with the
WT
2A-AR, the findings indicate that D79 is
critical in regulating
2AAR functional coupling to G proteins.
The position of the Gpp(NH)p curve reflects not
only the affinity of Gpp(NH)p for the G proteins involved,
but also the efficiency of G protein coupling to receptors,
because Gpp(NH)p binding to the G protein (and consequent G protein
conformational changes) leads to dissociation of the R-G complex,
decreased receptor affinity for agonist, and thus diminished
trapability of the [125I]PIC binding (Fig. 1C,
schematic). Because the [125I]PIC binding
detected for WT and
2A-AR mutant structures in these studies was pertussis toxin-sensitive (data not shown), the
implication is that similar G proteins are involved in these interactions in the transient expression studies performed.
Consequently, differences in the EC50 for
Gpp(NH)p reflect differences in R-G coupling efficiency and retrograde
G
R signaling from a similar pool of G proteins to different (WT
versus mutant) receptor structures. Gpp(NH)p is more potent in
decreasing high affinity agonist binding to the N422D
[EC50 64 ± 7.5 nM (mean ± SE);
n = 3] and D79N/N422D
2AAR
(EC50 22 ± 4 nM; n = 3)
structures when compared with wild-type
2AAR
(EC50 257 ± 39 nM (mean ± SE;
n = 3; Fig. 1C). A leftward shift in the Gpp(NH)p
concentration response curve for decreasing [125I]PIC trapability denotes an
increased efficiency with which Gpp(NH)p dislodges high
efficiency R-G interactions and is consistent with the interpretation
that the functional interface between the D79N/N422D
2AAR or the N422D
2AAR may be more fragile than between the WT
2AAR and thus more easily disrupted by guanine nucleotides.
Allosteric Modulation of Ligand Binding by Na+
Correlates with Membrane-Embedded Asp, but Not Asn, Residues.
Agonist (epinephrine) competition for binding of the radiolabeled
antagonist ([3H]RX821002), in the presence or
absence of Na+, was used to evaluate allosteric
modulation of ligand binding to the
2AAR by
monovalent cations (Tsai and Lefkowitz, 1978
; Michel et al., 1980
;
Nunnari et al., 1987
). As shown in Fig. 1D, the wild-type
2AAR exhibits allosteric modulation, as
manifested by a rightward shift of the epinephrine competition curve in
the presence of Na+ because of
Na+-evoked decreases in receptor affinity for
agonists. This shift in the competition curve in the presence of
Na+ solely reflects a decrease in the receptor
affinity for epinephrine, because [3H]RX821002
seems to be insensitive to allosteric modulation in its affinity for
2AAR (MacMillan et al., 1996
) in contrast to Na+-evoked increases in receptor affinity for the
antagonist [3H]yohimbine (Nunnari et
al., 1987
). Allosteric modulation of agonist binding by
Na+ is lost in the D79N
2AAR, indicated by a lack of effect of
Na+ on epinephrine competition for
[3H]RX821002 (Fig. 1E), corroborating the role
of aspartate D79 in allosteric modulation of ligand binding by cations
in the
2AAR (Horstman et al., 1990
) and in a
variety of other GPCR (Neve et al., 1991
; Kong et al., 1993
; Tian and
Deth, 1993
). Interchange of the aspartate in TM7 with the asparagine in
TM7, creating the D79N/N422D
2AAR double
mutant, creates an intermediate phenotype of allosteric modulation of
ligand binding (Fig. 1G). Not surprisingly, the single mutant N422D
2AAR (Fig. 1F) also exhibits allosteric modulation of agonist binding by Na+, because
this structure contains an aspartate in both TM2 and TM7 that both
could serve as negative counterions for the Na+
cation. All of the
2AAR mutants studied (i.e.,
D79N, N422D, or D79N/N422D) seem to possess a higher affinity for
agonist than the wild-type
2AAR, manifested as
a shift to the left in the agonist competition curve in the absence of
Na+ [receptor structure
EC50 (n = 3): WT, 9.5 ± 2 µM; D79N, 1.4 ±1 µM*; N422D, 1.0 ± 0.5 µM*; D79N/N422D,
1.6 ± 0.8 µM* (*p < 0.05 compared with WT)
(Fig. 1, D-G)], as reported previously for the D79N mutation in the
2AAR (Horstman et al., 1990
; Lakhlani et al.,
1997
).
Impact of the Presumed
2AAR Asp79(TM2)/Asn422(TM7)
Interface on MAP Kinase Activation.
Previous studies have
demonstrated a selective inability of the
D79N
2AAR to activate G protein

-dependent pathways (Surprenant et al., 1992
), such as the
activation of receptor-operated K+ currents
(Clapham and Neer, 1993
) compared with
subunit-involved pathways
such as inhibition adenylyl cyclase or voltage-gated Ca2+ currents (Surprenant et al., 1992
; Lakhlani
et al., 1996
). Because the D79N mutation is also known to result in
ablation of allosteric modulation of ligand binding (Horstman et al.,
1990
), it is reasonable to postulate a functional link between
allosteric modulation of receptor conformation and activation of

-dependent pathways, corresponding to the postulated link between
Na+ modulation of receptor affinity and
receptor-
subunit interactions (Costa et al., 1992
; Onaran et
al., 1993
).

-dependent pathway, especially for the
2AAR (van Biesen et al., 1995
2AAR is able to activate the MAP kinase in
response to epinephrine in a concentration-dependent manner in HEK 293 cells. Activation of the MAP kinase is not detected for the
D79N
2AAR, despite similar levels of D79N and
mutant receptor expression as WT receptor in these experiments.
Epinephrine activates MAP kinase via the
N422D
2AAR, although with a trend of a reduced potency (note trend of rightward shift in the
EC50 value for epinephrine to activate MAP
kinase in N422D
2A-AR-expressing cells
compared with cells expressing the WT
2A-AR)
contrasting with the increased affinity for agonist ligand
for this receptor structure (Fig. 1, D and G). Taken together, these
observations indicate that the efficacy of
N422D
2AAR coupling to G proteins is less than that of the wild-type
2AAR, corroborating the
interpretations of the increased sensitivity of
125I-PIC binding to Gpp(NH)p for the
N422D
2AAR (Fig. 1C). Interchange of residues
79 and 422, creating the D79N/N422D double mutant
2AAR, also permits MAP kinase activation by
epinephrine in a dose-dependent manner, but with a diminished potency
compared with the wild-type
2AAR (Fig. 2 and Tables 1 and
2). This finding is again
consistent with the interpretation of findings in Fig. 1 that the D79N
and N422D residues contribute to an interface between TM2 and TM7 that
regulates receptor signaling properties.
|
|
|
Mutation of Residues 79 or 422 Alters Cell Surface Receptor
Turnover and Results in Ligand Modulation of Receptor Turnover and
Density.
Recently, we demonstrated that the D79N
2AAR manifests a higher rate of cell-surface
turnover and that this turnover can be slowed by receptor structural
stabilization with either agonist or antagonist occupancy, resulting in
steady-state receptor density up-regulation (Wilson and Limbird,
2000
). The N422D
2AAR, despite retention
of allosteric modulation of ligand binding by Na+
(Fig. 2I), possesses a surface t1/2 of <3
h compared with the 13 ± 1.0 h surface
t1/2 of wild-type
2AAR (Fig. 3A).
The N422D
2AAR also exhibits receptor density
up-regulation by antagonist but not by agonist (Fig. 3C); similarly,
antagonist, but not agonist, occupancy of the receptor slows cell
surface receptor turnover (Fig. 3B).
|
2AAR slows the surface
t1/2 to 4.7 ± 0.3 h for the
D79N/N422D
2AAR (Fig. 3A) compared with the
<3 h t1/2 characteristic of the single mutant N422D
2AAR. Turnover of the
D79N/N422D
2AAR is slowed by occupancy of the
mutant
2AAR with either agonist or antagonist (Fig. 3B) and both agonist and antagonist similarly up-regulate receptor density of the D79N/N422D
2AAR (Fig.
3C), recapitulating findings for the D79N
2AAR
(Fig. 3, B and C). Thus, although the D79N/N422D double mutant exhibits
allosteric modulation by Na+ and functional
2AAR-G protein coupling (Fig. 1), receptor
stabilization on the cell surface is not fully restored to that
characteristic of the WT
2AAR, analogous to
findings for MAP kinase activation by epinephrine at the D79N/N422D
2AAR.
Consequences of Mutations At the Presumed Asp79(TM2)/Asn422(TM7)
Interface on
2aAR Conformational Stability.
Accelerated cell surface receptor turnover, in the context of
ligand-mediated increases in receptor density expression in cells, can
be a manifestation of the structural or conformational lability of a
receptor (Wilson and Limbird, 2000
). A direct measure of conformational
lability in mutant GPCRs is a comparison of the rate of loss of
receptor binding capability (a reflection of conformational/structural
stability) with the rate of loss of receptor protein (a reflection of
protein stability) in detergent-solubilized preparations (Gether et
al., 1997
; Wilson and Limbird, 2000
). As shown in Fig.
4, the N422D
2AAR is extremely
structurally/conformationally unstable compared with wild-type or even
D79N
2AAR (Fig. 4), which might be expected
given the presumed juxtaposition of two negative charges within the
bilayer of the
2AAR structure. Placing the
D79N mutation in the N422D structure (D79N/N422D) creates an
2AAR structure with an intermediate phenotype
for conformational stability compared with either single mutation (D79N
or N422D) alone (Fig. 4), based on the approximate
t1/2 of functional binding capacity in
detergent solution of 10 min for N422D, 1.5 h for D79N and 20 min
for D79N/N422D.
|
Additional Mutagenesis at Residue 79 Reveals the Critical
Importance of the Aspartate 79 Residue Per Se in Regulating Receptor
Cell-Surface Residence Time and Structural Stability.
The
observation that interchanging the aspartate in TM2 with the asparagine
in TM7, generating the D79N/N422D
2AAR double mutant, diminishes cell-surface residence time and enhances structural lability in detergent solution when compare to the wild-type
2AAR implies that simply complementing the
asparagine at 79 with a negative charge at this TM2/TM7 interface
(N422D) is not sufficient to impart functional properties identical
with that of the wild-type receptor. To explore this interpretation
further, two additional mutant
2AAR structures
were examined. The D79E
2AAR substitutes the
negatively charged aspartate with a negatively charged glutamate at
this TM2/TM7 interface. Previous studies from our laboratory have
demonstrated that the D79E
2AAR couples to G
proteins and is allosterically modulated by cations in a manner
indistinguishable from the WT
2AAR (Ceresa and
Limbird, 1994
). However, mutation of aspartate to glutamate does more
than simply substitute a negative charge with another, but also extends
the presumed negative charge by one methylene group. Another mutation
of residue 79, the D79Q
2AAR, previously
demonstrated to diminish G protein coupling efficiency and eliminate
allosteric modulation by cations (Ceresa and Limbird, 1994
), also was
examined. The rate of cell-surface turnover of both the D79E and D79Q
2AAR is more rapid than that of the wild-type
2AAR (Fig. 3A). Additionally, both the D79E and D79Q
2AAR are up-regulated in receptor
density after incubation with either agonist or antagonist in intact
cells (Fig. 3C), presumably because of ligand-mediated receptor
stabilization and slowing of cell-surface receptor turnover (Fig. 3B).
2AARs reveals that even the presumed
conservative substitution of aspartate 79 with glutamate results in
accelerated loss of binding activity in detergent compared with
wild-type
2AAR (Fig. 4). Interestingly, the
rate of loss of binding capability in detergent for the D79E
2AAR parallels the rate of loss for the
D79N/N422D
2AAR. These are important findings,
because they indicate that allosteric modulation by cations and
coupling to G proteins, both of which are true for the D79E and
D79N/N422D
2AARs, do not necessarily rely on
or predict a conformationally/structurally stable receptor structure
[(Ceresa and Limbird, 1994| |
Discussion |
|---|
|
|
|---|
Cell-surface receptor expression is necessary for surface-mediated
GPCR signaling. Conformational stability contributes to maintaining
cell surface receptor expression of GPCR in general and the
2AAR in particular. Mutant
2-AR receptors lacking conformational stability exhibit a faster removal from the cell surface that can be slowed by receptor occupancy with ligand [Fig. 3 and 4 and
(Wilson and Limbird, 2000
)]. Previous investigations have focused on
ligand mediated up-regulation of mutant GPCRs through either increased
cell-surface delivery (Morello et al., 2000
) or increased cell-surface
residence time (Wilson and Limbird, 2000
). The present study suggests
that the conserved D79(TM2)/N422(TM7) interface contributes to
conformational stability of the
2AAR, and,
because of the conserved nature of this interface, such findings may be
generalizable to other GPCRs. The multiple functional and structural
properties evaluated in this study for mutations at this interface are
summarized in Tables 1 and 2.
Considerable modeling of the predicted interactions among amino acid
side chains in the TM spans of GPCR has been undertaken, particularly
for receptors that bind monoamines (Sealfon et al., 1995
; Mizobe et
al., 1996
; Gether and Kobilka, 1998
). These models, developed to
describe a molecular basis for experimental data (Zhou et al., 1994
;
Sealfon et al., 1995
), suggest that TM2 and TM7 are in near each other
and that a hydrogen bonding network, including an aspartate in TM2 (D79
of the
2AAR) and an asparagine in TM 7 (N422
of the
2AAR), regulates receptor activation
(Fig. 1, A and B). Therefore, to interpret our results in the context of the
2A-AR, it was first important to
evaluate mutations at this interface with regard to receptor activation.
Allosteric modulation of ligand binding to the
2AAR seems to be dependent on a negative
charge at the TM2/TM7 interface. All receptor structures that possess a
negative charge in either TM2 (wild-type), TM7 (D79N/N422D), or both
TM2 and TM7 (N422D) result in allosteric modulation by monovalent
cations (Fig. 1, Tables 1 and 2). The ability of receptor to be
allosterically modulated by cations correlates with G protein coupling
efficiency, because receptors that undergo allosteric modulation
(wild-type, N422D, or D79N/N422D) also exhibit high affinity guanine
nucleotide-sensitive agonist binding (Fig. 1C and Table 1). In
contrast, receptors that lack allosteric modulation by cations (D79N)
do not possess guanine-nucleotide sensitive agonist binding (Fig. 1, C
and D; Table 1), a measure of retrograde coupling of G proteins to
cognate receptors (Ceresa and Limbird, 1994
). The ability of receptors to couple to G proteins in membrane preparations correlates with the
ability of receptor to activate MAP kinase in intact cells, a measure
of anterograde receptor to G protein coupling. Thus, receptors that
undergo modulation of ligand binding by cations (wild-type, N422D, and
D79N/N422D
2AARs) also activate the MAP kinase
cascade; those that lack allosteric modulation by cations or regulation
of agonist binding by Gpp(NH)p (e.g., the D79N
2AAR in Fig. 1, C and E) do not. Collectively,
these results regarding allosteric modulation by
Na+ and receptor-G protein coupling correlate
with data previously obtained for other GPCR with regards to modulating
the structure of GPCR at the presumed TM2/TM7 interface (Table 1).
The conserved TM2/TM7 interface also seems to play some role in
regulating receptor cell surface residence time. Thus, mutation of D79
to N, E, or Q in the
2AAR is paralleled by
faster cell surface receptor turnover (Fig. 3) and structural
instability (Fig. 4), despite differing consequences on receptor
activation (Wilson and Limbird, 2000
). Mutation of TM7 at the TM2/TM7
interface to create a receptor with presumably apposing negative
charges (i.e., the N422D
2AAR) leads to an
extremely unstable
2AAR molecule, as measured
by multiple independent lines of evidence including: 1) accelerated
rate of loss functional binding capacity after detergent solubilization
(Fig. 4); 2) increased cell surface receptor turnover (Fig. 3A); 3)
ligand-stabilized attenuation of receptor turnover (Fig. 3B); and 4)
ligand-mediated, steady-state up-regulation of receptor density (Fig.
3C). It is probable that the extreme structural instability of the
N422D
2AAR results from apposition of two
negatively charged residues near each other within the transmembrane
domain core of the
2AAR. It is interesting
that only antagonist occupancy, but not agonist occupancy, serves to stabilize the surface residence of the
N422D
2AAR, resulting in dramatic up-regulation
of N422D
2AAR density. It is possible that antagonist occupancy of the receptor stabilizes a conformation in which
the interaction of the negatively-charged residues D79(TM2) and
N422D(TM7) does not occur. In contrast, the agonist epinephrine, by
stabilizing a distinct conformation, may foster a more direct interaction of these two residues, resulting in a considerably more
unstable receptor structure, thus accounting for the lack of effect of
epinephrine on cell surface receptor stabilization and resultant
up-regulation of steady state receptor density. Such an interpretation
is consistent with other lines of evidence that agonists and
antagonists serve to stabilize differing receptor conformations (Gether
and Kobilka, 1998
). Placing the D79N mutation within the
N422D
2AAR structure restores some structural
stability, which manifests as a decrease in the loss of functional
binding capacity after detergent solubilization (Fig. 4) and a slower surface turnover in intact cells (Fig. 3A), presumably because of
removal of one of the negative charges at this interface.
The properties of the D79E and D79N/N422D
2AAR
structures, compared with those of wild-type
2AAR, reveal the critical importance of the
precise structural localization of the negative charge on the side
chain of residue 79 in regulating receptor structural stability.
Although the D79E
2AAR couples to G proteins
and its binding of agonist and antagonist ligands is modulated by
monovalent cations in a way that is indistinguishable from the WT
2AAR (Ceresa and Limbird, 1994
), the D79E
2AAR exhibits structural instability like that
of the D79N/N422D
2AAR double mutant (Fig. 4).
Thus, although a negative charge at residue 79 is necessary to permit functional activity of the
2AAR, it is not
sufficient to afford all of the properties of the wild-type receptor,
including intrinsic conformational/structural stability and prolonged
receptor cell-surface residence time (Table 2).
Our data are consistent with a proximity of the TM2 and TM7
transmembrane helices, by analogy with the amine binding
5HT2A receptor and the peptide binding GnRH-R and
µ-opioid receptor (Zhou et al., 1994
; Sealfon et al., 1995
; Flanagan
et al., 1999
; Xu et al., 1999
). It is probable that this interface
involves multiple independent or interdependent contact sites. However, our data are not necessarily consistent with a direct charge pairing of
D79 in TM2 with N442 in TM7, because "swapping" of these residues via mutagenesis does not create a receptor structure (D79N/N422D) with
functional or stability properties indistinguishable from the wild-type
receptor. This interpretation is consistent with recent
crystallographic findings for another GPCR, rhodopsin, suggesting that
a molecule of water bridges these two residues (Palczewski et al.,
2000
). Nonetheless, our data are consistent with the interpretation
that the two residues do contribute to this TM2-TM7 interface, which
regulates multiple biochemical properties of the
2A-AR (Tables 1 and 2).
For the
2AAR, possessing a negative charge in
TM2(D79), TM7 (D79N/N422D), or both TM2 and TM7 (N422D) is sufficient
to impart allosteric modulation of ligand binding by monovalent
cations, coupling to G proteins, and activation of MAP kinase activity. However, this interface also is essential for maintaining intrinsic receptor conformational/structural stability. Receptor structural stability seems to be more sensitive than receptor activation to
structural modification by mutation of residues at this interface, borne out by the observation of the extreme structural instability of
the N422D
2AAR as well as structural
instability of the conservatively substituted D79E
2AAR. Taken together, these data suggest that this TM2/TM7 interface in GPCRs is involved in two distinct phenomena: receptor activation (measured by G protein coupling and activation of
downstream effectors) and receptor conformational stability (measured
directly by following receptor binding in detergent solution over time
and indirectly as receptor cell-surface residence time) (Tables 1 an
2). Elucidation of sites critical for regulating or maintaining GPCR
conformational/structural stability as well as cell-surface expression
is an important step in providing novel therapeutic/pharmacological
modulation of GPCR. This highly conserved TM2/TM7 interface seems to be
one such critical site, especially because of its role in regulating
receptor activation.
| |
Acknowledgments |
|---|
We thank Carol Ann Bonner for superior technical assistance with cell culture for these studies and Stephen W. Edwards, Ph.D., for helpful advice regarding the molecular modeling studies. M.H.W. would like to thank his Ph.D. dissertation committee for helpful advice and discussions. Finally, we thank all members of the Limbird lab for shared enthusiasm and support.
| |
Footnotes |
|---|
Received October 16, 2000; Accepted January 3, 2001
This work was supported by National Institutes of Health Grant HL43671 to L.E.L. and Medical Scientist Training Program Grant GM07347 for M.H.W.
Send reprint requests to: Dr. Lee E. Limbird, Department of Pharmacology, 468 MRB I, Vanderbilt University Medical Center, Nashville, Tennessee. E-mail: lee.limbird{at}mcmail.vanderbilt.edu
| |
Abbreviations |
|---|
2AR,
2-adrenergic
receptor;
GPCR, G protein-coupled receptors(s);
TM, transmembrane
domain;
MAP, mitogen activated protein;
GnRH, gonadotropin-releasing
hormone;
HA, hemagglutinin;
CHO, Chinese hamster ovary;
EcR, ecdysone
receptor-expressing;
HEK, human embryonic kidney;
FCS, fetal calf
serum;
PMSF, phenylmethylsulfonyl fluoride;
[125I]PIC, para-[125I]iodoclonidine;
GppNHp, 5'-guanylylimidodiphosphate;
WT, wild-type;
PAGE, polyacrylamide gel
electrophoresis;
D
M/CHS, dodecyl-
-D-maltoside/cholesteryl hemisuccinate;
CAPS, 3-(cyclohexylamino)propanesulfonic acid;
t1/2, half-life.
| |
References |
|---|
|
|
|---|
2-adrenergic receptors.
Mol Pharmacol
38:
348-56[Abstract].
2- adrenergic receptor-G-protein interactions. A negative charge at amino acid residue 79 forecasts
2A-adrenergic receptor sensitivity to allosteric modulation by monovalent cations and fully effective receptor/G-protein coupling.
J Biol Chem
269:
29557-29564
-dimers in transmembrane signalling.
Nature (Lond)
365:
403-406[Medline].
2A-adrenergic receptor.
J Biol Chem
274:
16331-16336
2-adrenergic receptor.
Mol Pharmacol
38:
214-221[Abstract].
2-adrenergic receptors by sodium.
J Biol Chem
265:
21590-21595
2A-adrenergic receptor on the basolateral membrane of Madin-Darby canine kidney cells.
J Biol Chem
269:
16425-16432
opioid receptor specifies selective high affinity agonist binding.
J Biol Chem
268:
23055-23058
2A-adrenergic receptor inhibition of stimulus-secretion coupling.
Mol Pharmacol
50:
96-103[Abstract].
2-adrenergic receptors by Na+, H+ and inhibitors of Na+/H+ exchange.
J Biol Chem
262:
12387-12392
subunits of guanine nucleotide-binding proteins and regulation of spontaneous receptor activity: Thermodynamic model for the interaction between receptors and guanine nucleotide-binding protein subunits.
Mol Pharmacol
43:
245-256[Abstract].
2-adrenergic receptors does not require agonist-elicited endocytosis.
J Biol Chem
274:
24935-24940